Fig. 7 | Scientific Reports

Fig. 7

From: Comprehensive analysis of prognosis and drug sensitivity of programmed cell death pattern-related genes in gastric cancer patients

Fig. 7

Prediction of drug sensitivity based on the CDI model and CDI-associated immunotherapy. (A) Relationships among drug sensitivity, CDI model risk score, and 17 PCD-related prognostic DEGs. (B) CDI model risk score in samples with progressive disease (PD), stable disease (SD), complete response (CR), and partial response (PR). (C) Percentage of CR/PR and PD/SD in high-risk and low-risk CDI groups. (D) Expression of the 17 PCD-related prognostic DEGs between CR/PR and PD/SD groups. (E) Top 10 immune checkpoints in high-risk and low-risk CDI groups. (F) KM survival curves in high- and low-risk CDI groups. (G) CDI model risk score in samples with PD, SD, CR, and PR. * P < 0.05, ** P < 0.01, *** P < 0.001, ns: not significant.

Back to article page